Inmune Bio (INMB) Return on Capital Employed [ROCE] (2019 - 2026)
Inmune Bio (INMB) posted Return on Capital Employed [ROCE] of -98.79% for Q2 2026, up 94.06 percentage points from -192.85% a year earlier and up 83.89 percentage points from the prior quarter.
Powered by 
Analysis
Inmune Bio (INMB) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends
For FY2025, Inmune Bio's Return on Capital Employed [ROCE] came in at -172.05%, down 68.21 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] has declined for three consecutive years, with a five-year change of -132.33 percentage points (FY2020 to FY2025).
- In prior years, Inmune Bio's Return on Capital Employed [ROCE] was -103.83% in FY2024 (-45.44 pp), -58.39% in FY2023 (-25.93 pp), -32.46% in FY2022 (+11.75 pp) and -44.21% in FY2021 (-4.49 pp).
- The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q4 2023.
- On a year-over-year basis, Return on Capital Employed [ROCE] increased in 1 of the last eight quarters, with an average year-over-year change of -40.62 percentage points.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q2 2026, with a gain of 94.06 percentage points; the weakest was Q4 2025, with a drop of 84.43 percentage points.
- According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -182.69% (Q1 2026), -193.89% (Q4 2025) and -182.42% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Inmune Bio | 30.71 Mn | -50.14 Mn | - | -83.59% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -83.59% |
| Jun 30, 2026 | -98.79% |
| Mar 31, 2026 | -182.69% |
| Dec 31, 2025 | -193.89% |
| Sep 30, 2025 | -182.42% |
| Jun 30, 2025 | -192.85% |
| Mar 31, 2025 | -135.01% |
| Dec 31, 2024 | -109.46% |
| Sep 30, 2024 | -107.10% |
| Jun 30, 2024 | -109.24% |
| Mar 31, 2024 | -99.62% |
| Dec 31, 2023 | -71.87% |
| Sep 30, 2023 | -52.08% |
| Jun 30, 2023 | -44.08% |
| Mar 31, 2023 | -38.31% |
| Dec 31, 2022 | -36.10% |
| Sep 30, 2022 | -37.18% |
| Jun 30, 2022 | -34.82% |
| Mar 31, 2022 | -33.09% |
| Dec 31, 2021 | -29.31% |
API Access
Inmune Bio Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=INMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "INMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=INMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();